SSP
AGN

Sapphire Star Partners’s Allergan plc AGN Stock Holding History

Sapphire Star Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$205K – 112
2017
Q3 		$205K Hold
1,000
– – 0.27% 77
2017
Q2 		$243K Hold
1,000
– – 0.31% 56
2017
Q1 		$239K Hold
1,000
– – 0.27% 76
2016
Q4 		$210K Hold
1,000
– – 0.23% 85
2016
Q3 		$230K Buy
+1,000
New +$244K 0.28% 58

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Sapphire Star Partners's AGN Position: Q4 2017 in Review

Sapphire Star Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,000 shares — an estimated $205K sold.

Sapphire Star Partners first reported a position in AGN in Q3 2016 and held it in 5 quarters. The position peaked at $243K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Sapphire Star Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Sapphire Star Partners sold 1,000 Allergan plc shares in Q4 2017, an estimated $205K.
  • Sapphire Star Partners first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
  • Sapphire Star Partners's Allergan plc position peaked at $243K in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Sapphire Star Partners's 13F filing for Q4 2017, filed 14 Feb 2018.